Morgan Stanley’s Morphic Holding, Inc. Common Stock MORF Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-152,366
| Closed | -$5.19M | – | 8102 |
|
|
2024
Q2 | $5.19M | Sell |
152,366
-68,209
| -31% | -$2.02M | ﹤0.01% | 3840 |
|
|
2024
Q1 | $7.76M | Sell |
220,575
-1,171,265
| -84% | -$39.3M | ﹤0.01% | 3545 |
|
|
2023
Q4 | $40.2M | Buy |
1,391,840
+863,402
| +163% | +$20.6M | ﹤0.01% | 2680 |
|
|
2023
Q3 | $12.1M | Buy |
528,438
+265,627
| +101% | +$13.9M | ﹤0.01% | 2945 |
|
|
2023
Q2 | $15.1M | Buy |
262,811
+115,453
| +78% | +$6.03M | ﹤0.01% | 2764 |
|
|
2023
Q1 | $5.55M | Sell |
147,358
-60,038
| -29% | -$2.21M | ﹤0.01% | 3697 |
|
|
2022
Q4 | $5.55M | Sell |
207,396
-42,821
| -17% | -$1.17M | ﹤0.01% | 3658 |
|
|
2022
Q3 | $7.08M | Sell |
250,217
-161,300
| -39% | -$4.5M | ﹤0.01% | 3331 |
|
|
2022
Q2 | $8.93M | Buy |
411,517
+191,656
| +87% | +$5.35M | ﹤0.01% | 3181 |
|
|
2022
Q1 | $8.83M | Buy |
219,861
+106,424
| +94% | +$4.45M | ﹤0.01% | 3054 |
|
|
2021
Q4 | $5.38M | Buy |
113,437
+59,614
| +111% | +$3.2M | ﹤0.01% | 3645 |
|
|
2021
Q3 | $3.05M | Sell |
53,823
-39,787
| -43% | -$2.41M | ﹤0.01% | 4207 |
|
|
2021
Q2 | $5.37M | Sell |
93,610
-25,430
| -21% | -$1.4M | ﹤0.01% | 3708 |
|
|
2021
Q1 | $7.53M | Sell |
119,040
-157,627
| -57% | -$7.24M | ﹤0.01% | 2963 |
|
|
2020
Q4 | $9.28M | Buy |
276,667
+221,849
| +405% | +$6.56M | ﹤0.01% | 2590 |
|
|
2020
Q3 | $1.5M | Buy |
54,818
+5,853
| +12% | +$153K | ﹤0.01% | 3909 |
|
|
2020
Q2 | $1.32M | Buy |
48,965
+47,887
| +4,442% | +$896K | ﹤0.01% | 3944 |
|
|
2020
Q1 | $16K | Sell |
1,078
-5,805
| -84% | -$97.3K | ﹤0.01% | 5895 |
|
|
2019
Q4 | $118K | Buy |
6,883
+5,036
| +273% | +$78.5K | ﹤0.01% | 5601 |
|
|
2019
Q3 | $34K | Buy |
+1,847
| New | +$38.7K | ﹤0.01% | 5858 |
|
Other funds holding MORF
Morgan Stanley's MORF Position: Q3 2024 in Review
Morgan Stanley sold out of Morphic Holding, Inc. Common Stock (MORF) in Q3 2024, closing a stake of 152,366 shares — an estimated $5.19M sold.
Morgan Stanley first reported a position in MORF in Q3 2019 and held it in 20 quarters. The position peaked at $40.2M in Q4 2023. 2 funds tracked by Wall St. Rank hold MORF as of Q3 2024.
- Morgan Stanley reported no remaining Morphic Holding, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
- Morgan Stanley sold 152,366 Morphic Holding, Inc. Common Stock shares in Q3 2024, an estimated $5.19M.
- Morgan Stanley first reported a position in Morphic Holding, Inc. Common Stock in Q3 2019 and held it in 20 quarters.
- Morgan Stanley's Morphic Holding, Inc. Common Stock position peaked at $40.2M in Q4 2023.
- 2 funds tracked by Wall St. Rank held Morphic Holding, Inc. Common Stock as of Q3 2024.
Based on Morgan Stanley's 13F filing for Q3 2024, filed 14 Nov 2024.